查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1515549

基因組測試市場，按測試類型、疾病、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Genome Testing Market, By Test Type, By Disease, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 398 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年基因組測試市場規模為 89.542 億美元，2024 年至 2032 年複合年成長率為 22.50%。

基因組檢測市場-市場動態

各種應用中 DNA 檢測的需求不斷成長

診斷測試用於識別或排除特定的遺傳或染色體異常。當身體體徵和症狀表明存在問題時，通常會使用基因檢測來確認診斷。儘管診斷測試並非適用於所有基因或遺傳狀況，但可以在出生前或個人一生中的任何時間進行。診斷測試的結果可能會影響醫療護理和疾病管理的決策。 DNA 序列用於法醫檢測，以出於合法目的識別個人身分。這種測試可用於建立人與人之間的生物關係、識別犯罪或悲劇的受害者、排除或牽連犯罪嫌疑人等。

基因組測試市場 - 關鍵見解

我們的研究分析師估計，2024年至2032年全球市場將以約22.50%的複合年成長率發展。

根據測試類型細分，診斷測試產業在 2023 年佔據了最大的收入佔有率。

根據疾病細分，到 2023 年，癌症將主導市場。

按地區分類，北美是 2023 年的主要收入來源

基因組測試市場-細分分析：

全球基因組測試市場根據測試類型、疾病和地區進行細分。

根據測試類型，市場分為七類：攜帶者測試、預測測試、診斷測試、產前和新生兒測試、營養基因組學、藥物基因組學等。就2023年的收入而言，診斷測試領域在全球基因測試市場佔據主導地位，預計在預測期內將保持其主導地位。這僅僅是由於全球人口中慢性病的發生率不斷上升。一項調查顯示，近 60% 的美國人患有至少一種慢性病。此外，老年人口的迅速成長以及老年人口診斷測試需求的增加推動了近年來該領域的擴張。

市場依疾病分為七類：癌症、阿茲海默症、地中海型貧血、囊性纖維化、亨丁頓舞蹈症、杜氏肌肉營養不良症和其他疾病。就2023年的收入而言，癌症類別控制著全球基因檢測市場，預計在預測期內將保持其主導地位。這僅僅是由於全球人口中癌症盛行率不斷上升。乳癌、肺癌、腸癌和子宮癌等癌症盛行率的上升是此類癌症的主要促進因素。

基因組測試市場-地理洞察

從地理來看，該市場存在於北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些區域根據哪些國家帶來業務進一步分類。就2023年的收入而言，北美在全球基因檢測市場上佔據主導地位，並且預計其主導地位在預測期內將持續下去。這可能是由於消費者越來越了解基因檢測對一般人群的好處。此外，在美國等國家，透過線上網站廣泛提供自檢試劑盒增加了人們對基因檢測試劑盒的使用。此外，大多數人口中慢性病盛行率不斷上升，加上消費者在醫療保健方面的支出增加，加速了市場擴張。美國不斷成長的老年人口可能會在未來幾年推動市場發展。

由於中國、印度、韓國和日本的龐大目標族群，亞太地區是成長最快的市場。此外，市場擴張的主要驅動力之一是擴大使用現代實驗室技術和技術，例如 DNA 測序，用於快速檢查和診斷慢性和傳染病。

基因組測試市場-競爭格局：

在基因組測試市場競爭格局中，多家公司競相提供先進的基因組測試服務和產品。 Genentech Inc.、Sorenson Genomics, LLC、Abbott Molecular、Bayer Diagnostics 和 Biocartis 是生產尖端基因組定序和分析技術的領先公司。這些組織旨在透過投資研發、建立策略聯盟和引入新穎的測試解決方案來保持競爭力。了解競爭環境可以提供對市場動態的有用見解，使組織能夠在基因組測試產業中做出明智的決策。

最近的發展：

2022 年 1 月，ARCHIMED Life 與 Amides Holding GmbH 達成策略協議，以增加和改善遺傳、生化和生物標記測試的獨特診斷服務的取得。

目錄

第1章：基因組測試市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按測試類型分類的基因組測試市場片段
    • 按疾病分類的基因組測試市場片段
    • 按國家/地區分類的基因組測試市場片段
    • 按地區分類的基因組測試市場片段
  • 競爭洞察

第 3 章：基因組測試主要市場趨勢

  • 基因組測試市場促進因素
    • 市場促進因素的影響分析
  • 基因組測試市場限制
    • 市場限制影響分析
  • 基因組測試市場機會
  • 基因組測試市場未來趨勢

第 4 章：基因組測試產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：基因組測試市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：基因組測試市場格局

  • 2023 年基因組測試市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：基因組測試市場 - 按測試類型

  • 概述
    • 按測試類型分類的細分市場佔有率分析
    • 營運商測試
    • 預測測試
    • 診斷測試
    • 產前和新生兒檢測
    • 營養基因體學
    • 藥物基因組學
    • 其他

第 8 章：基因組測試市場 - 按疾病分類

  • 概述
    • 按疾病分類的細分市場佔有率分析
    • 癌症
    • 老年失智症
    • 地中海型貧血
    • 囊腫纖維化
    • 亨丁頓舞蹈症
    • 杜氏肌肉營養不良症
    • 其他疾病

第 9 章：基因組測試市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美基因組測試主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按測試類型）
    • 北美市場規模與預測（按疾病）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲基因組測試主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按測試類型）
    • 歐洲市場規模與預測（按疾病）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區基因組測試主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 按測試類型分類的亞太市場規模和預測
    • 亞太地區市場規模與預測（按疾病）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲基因組測試主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模和預測（按測試類型）
    • 拉丁美洲市場規模與預測（按疾病）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 基因組測試中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按測試類型）
    • 中東和非洲市場規模及預測（按疾病）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章：主要供應商分析 - 基因組測試產業

  • 競爭儀表板
  • 公司簡介
    • Genentech Inc.
    • Sorenson Genomics, LLC
    • Abbott Molecular
    • Bayer Diagnostics
    • Biocartis
    • BioHelix
    • Celera Genomics
    • Genomic Health
    • HTG Molecular Diagnostics
    • PacBio
    • Others

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3302

REPORT HIGHLIGHT

Genome Testing Market size was valued at USD 8,954.2 Million in 2023, expanding at a CAGR of 22.50% from 2024 to 2032.

DNA testing has several medical uses, including infant DNA screening, identity diagnostics and forensics, pre-natal DNA carrier screening, infectious disease diagnostics, oncology histopathology and diagnostics, and so on. Genetic testing involves the use of hair, blood, skin, and other samples. Depending on the suspected ailment, the sample is sent to a lab, where researchers look for specific proteins, DNA, or chromosome changes. Kits and panels are used in DNA testing to detect diseases in humans. Human blood samples are collected for DNA testing, and the tests are performed using test kits and lab equipment.

Genome Testing Market- Market Dynamics

Growing Need for DNA Testing in Various Applications

Diagnostic testing is used to identify or rule out a specific genetic or chromosomal abnormality. When physical signs and symptoms point to a problem, genetic testing is commonly used to confirm the diagnosis. Although diagnostic testing is not available for every gene or genetic condition, it can be performed prior to birth or at any time during an individual's life. A diagnostic test's results may influence decisions about medical care and disease management. DNA sequences are employed in forensic testing to identify individuals for legal purposes. This testing can be used to establish biological relationships between persons, identify victims of crime or tragedy, exclude or implicate a criminal suspect, and so on.

Genome Testing Market- Key Insights

Our research analyst estimates that the global market will develop at a CAGR of approximately 22.50% from 2024 to 2032.

Based on Test Type segmentation, the diagnostic testing sector accounted for the biggest revenue share in 2023.

Based on Disease segmentation, in 2023, cancer will dominate the market.

Based on region, North America was the leading revenue generator in 2023

Genome Testing Market- Segmentation Analysis:

The Global Genome Testing Market is segmented based on Test Type, Disease, and Region.

The market is divided into seven categories based on Test Type: Carrier Testing, Predictive Testing, Diagnostic Testing, Prenatal & Newborn Testing, Nutrigenomics, Pharmacogenomics and Others. The diagnostic testing segment dominated the worldwide genetic testing market in terms of revenue in 2023 and is expected to maintain its dominance during the forecast period. This is simply due to the rising frequency of chronic diseases in the worldwide population. According to a survey, almost 60% of the US population suffers from at least one chronic condition. Furthermore, the rapidly rising elderly population and increased need for diagnostic tests among them have propelled the segment's expansion in recent years.

The market is divided into seven categories based on Diseases: Cancer, Alzheimer's, Thalassemia, Cystic Fibrosis, Huntington's Disease, Duchenne Muscular Dystrophy, and Other Diseases. The cancer category controlled the global genetic testing market in terms of revenue in 2023 and is expected to maintain its dominance during the forecast period. This is simply due to the rising prevalence of cancer in the global population. The rising prevalence of cancers such as breast cancer, lung cancer, bowel cancer, and womb cancer are the primary drivers of this category.

Genome Testing Market- Geographical Insights

Geographically, this market is present in North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These zones are further split based on which countries bring business. North America dominated the global genetic testing market in terms of revenue in 2023, and its dominance is expected to continue during the forecast period. This can be due to growing consumer knowledge of the benefits of genetic testing in the general population. Furthermore, the widespread availability of self-testing kits via online websites in countries such as the United States has increased the population's use of genetic testing kits. Furthermore, the rising prevalence of chronic diseases among the majority of the population, combined with higher consumer spending on healthcare, has accelerated market expansion. The growing senior population in the United States is likely to drive the market in the coming years.

Asia Pacific is the fastest-growing market due to the vast target population in China, India, South Korea, and Japan. Furthermore, one of the primary drivers of market expansion is the growing use of modern laboratory techniques and techniques, such as DNA sequencing, for rapid examination and diagnosis of chronic and infectious ailments.

Genome Testing Market- Competitive Landscape:

In the Genome Testing Market Competitive Landscape, several companies compete to provide advanced genome testing services and products. Genentech Inc., Sorenson Genomics, LLC, Abbott Molecular, Bayer Diagnostics, and Biocartis are among the leading companies producing cutting-edge genome sequencing and analysis technology. These organizations aim to stay competitive by investing in R&D, creating strategic alliances, and introducing novel testing solutions. Understanding the competitive environment can provide useful insights into market dynamics, allowing organizations to make informed decisions in the genomic testing industry.

Recent Developments:

In January 2022, ARCHIMED Life formed a strategic agreement with Amides Holding GmbH to increase and improve access to unique diagnostic services for genetic, biochemical, and biomarker testing.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL GENOME TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Genentech Inc.

Sorenson Genomics, LLC

Abbott Molecular

Bayer Diagnostics

Biocartis

BioHelix

Celera Genomics

Genomic Health

HTG Molecular Diagnostics

PacBio

Others

GLOBAL GENOME TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Carrier Testing
  • Predictive Testing
  • Diagnostic Testing
  • Prenatal & Newborn Testing
  • Nutrigenomics
  • Pharmacogenomics
  • Others

GLOBAL GENOME TESTING MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Alzheimer's
  • Thalassemia
  • Cystic Fibrosis
  • Huntington's Disease
  • Duchenne Muscular Dystrophy
  • Other Diseases

GLOBAL GENOME TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genome Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genome Testing Market Snippet by Test Type
    • 2.1.2. Genome Testing Market Snippet by Disease
    • 2.1.3. Genome Testing Market Snippet by Country
    • 2.1.4. Genome Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Genome Testing Key Market Trends

  • 3.1. Genome Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genome Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genome Testing Market Opportunities
  • 3.4. Genome Testing Market Future Trends

4. Genome Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genome Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Genome Testing Market Landscape

  • 6.1. Genome Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genome Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Carrier Testing
    • 7.1.3. Predictive Testing
    • 7.1.4. Diagnostic Testing
    • 7.1.5. Prenatal & Newborn Testing
    • 7.1.6. Nutrigenomics
    • 7.1.7. Pharmacogenomics
    • 7.1.8. Others

8. Genome Testing Market - By Disease

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
    • 8.1.2. Cancer
    • 8.1.3. Alzheimer's
    • 8.1.4. Thalassemia
    • 8.1.5. Cystic Fibrosis
    • 8.1.6. Huntington's Disease
    • 8.1.7. Duchenne Muscular Dystrophy
    • 8.1.8. Other Diseases

9. Genome Testing Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Genome Testing Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Genome Testing Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Genome Testing Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Genome Testing Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Genome Testing Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Genome Testing Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Genentech Inc.
    • 10.2.2. Sorenson Genomics, LLC
    • 10.2.3. Abbott Molecular
    • 10.2.4. Bayer Diagnostics
    • 10.2.5. Biocartis
    • 10.2.6. BioHelix
    • 10.2.7. Celera Genomics
    • 10.2.8. Genomic Health
    • 10.2.9. HTG Molecular Diagnostics
    • 10.2.10. PacBio
    • 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Genome Testing Market: Test Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Test Type
  • TABLE Global Genome Testing Market, by Test Type 2019-2032 (USD Million)
  • TABLE Genome Testing Market: Disease Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease
  • TABLE Global Genome Testing Market, by Disease 2019-2032 (USD Million)
  • TABLE TABLE Genome Testing Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Genome Testing Market, by Region 2019-2032 (USD Million)
  • TABLE North America Genome Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Genome Testing Market, by Test Type, 2019-2032 (USD Million)
  • TABLE North America Genome Testing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Europe Genome Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Genome Testing Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Europe Genome Testing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genome Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genome Testing Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genome Testing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Latin America Genome Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Genome Testing Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Latin America Genome Testing Market, by Disease, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genome Testing Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genome Testing Market, by Test Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genome Testing Market, by Disease, 2019-2032 (USD Million)

List of Figures

  • FIGURE Genome Testing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Test Type segment market share analysis, 2023 & 2032
  • FIGURE Test Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Disease segment market share analysis, 2023 & 2032
  • FIGURE Disease segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Genome Testing Market share and leading players, 2023
  • FIGURE Europe Genome Testing Market share and leading players, 2023
  • FIGURE Asia Pacific Genome Testing Market share and leading players, 2023
  • FIGURE Latin America Genome Testing Market share and leading players, 2023
  • FIGURE Middle East and Africa Genome Testing Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Genome Testing Market share analysis by country, 2023
  • FIGURE Germany Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Genome Testing Market share analysis by country, 2023
  • FIGURE India Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Genome Testing Market share analysis by country, 2023
  • FIGURE Brazil Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Genome Testing Market share analysis by country, 2023
  • FIGURE Saudi Arabia Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Genome Testing Market size, forecast and trend analysis, 2019 to 2032 (USD Million)